Invention Grant
- Patent Title: Closed-loop blood glucose control systems and methods
-
Application No.: US16645436Application Date: 2018-08-01
-
Publication No.: US11484652B2Publication Date: 2022-11-01
- Inventor: Sylvain Rousson , Romain Blanc , Maeva Doron
- Applicant: DIABELOOP
- Applicant Address: FR Grenoble
- Assignee: DIABELOOP
- Current Assignee: DIABELOOP
- Current Assignee Address: FR Grenoble
- Priority: EP17306034 20170802
- International Application: PCT/EP2018/070901 WO 20180801
- International Announcement: WO2019/025506 WO 20190207
- Main IPC: A61M5/172
- IPC: A61M5/172 ; G16H20/17 ; G16H50/50 ; A61M5/142
Abstract:
An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (101), a subcutaneous insulin delivery device (103); and a controller (105) which determines a maximal allowable insulin injection amount and determines an insulin delivery control signal on the basis of the maximal allowable insulin injection amount and the quantity of insulin to inject.
Public/Granted literature
- US20200282141A1 CLOSED-LOOP BLOOD GLUCOSE CONTROL SYSTEMS AND METHODS Public/Granted day:2020-09-10
Information query
IPC分类:
